Preliminary reports suggest conolidine could inhibit specific ion channels, reducing neuronal excitability and restricting suffering signals. This mechanism is especially suitable in neuropathic soreness, exactly where irregular signaling will cause persistent soreness. On top of that, conolidine seems to affect G protein-coupled receptor (GPCR) pathways integral to pain perception. https://grahamg901pam6.mappywiki.com/user